Verenium Corporation (
Q3 2010 Earnings Call Transcript
November 9, 2010 5:00 pm ET
Kelly Lindenboom – VP, Corporate Communications
Carlos Riva – President and CEO
Janet Roemer – President and COO
Jamie Levine – EVP and CFO
Rob Walker – Jefferies
Paul Resnick – Olympia Capital Markets
Thank you for holding. Welcome to Verenium's third quarter 2010 financial results conference call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being taped at the company's request. At this time, I would like to introduce your host for today's call, Kelly Lindenboom. Please go ahead.
Thank you for joining Verenium's third quarter 2010 conference call. I'm Kelly Lindenboom, Vice President of Corporate Communications. And with me today are Carlos Riva, our Chief Executive Officer; Janet Roemer, our Chief Operating Office; and Jamie Levine, our Chief Financial Officer.
The agenda for today's call is as follows. First, Carlos will provide some remarks on the company following the completion of the BP transaction in September. Then Janet will discuss key assets of our business operations, including each of the major industries, our enzymes currently served, as well as our manufacturing efforts and business development activities. Jamie will then summarize our financial results for the third quarter of 2010, and we will then open the call up for your questions.
Before we begin, I would like to advise you that this discussion will include forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements involve a high degree of risk and uncertainty and relate to matters such as our strategy, future operating plans, markets for our products, partnering, collaboration activities, public policy and financing activities, technical and business outlooks.